Shuangyan Yang
Overview
Explore the profile of Shuangyan Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang S, Su B, Liu H
Transl Lung Cancer Res
. 2025 Jan;
13(12):3616-3628.
PMID: 39830749
Background: Stereotactic body radiation therapy (SBRT) is crucial for treating early-stage inoperable non-small cell lung cancer (NSCLC) due to its precision and high-dose delivery. This study aimed to investigate the...
2.
Yang S, Zhang Q
Chaos
. 2024 Sep;
34(9).
PMID: 39312727
Spatial heterogeneity, random disturbances in the external environment, and the incubation period of infected individuals collectively have a significant impact on the outbreak of avian influenza. In this paper, a...
3.
Liu D, Wu L, Xu X, Yang S, Liu M, Hu M, et al.
J Hematol Oncol
. 2024 Sep;
17(1):84.
PMID: 39272169
Combination of immunotherapy with radiotherapy is under active investigation. The PACIFIC trial firmly established the treatment paradigm of consolidation immunotherapy following definitive chemoradiotherapy, inspiring a series of similar or exploratory...
4.
Yan Y, Zhu Y, Yang S, Qian C, Zhang Y, Yuan X, et al.
Transl Lung Cancer Res
. 2024 Jun;
13(5):1069-1083.
PMID: 38854946
Background: Severe radiation pneumonitis (RP), one of adverse events in patients with lung cancer receiving thoracic radiotherapy, is more likely to lead to more mortality and poor quality of life,...
5.
Wu L, Cheng B, Sun X, Zhang Z, Kang J, Chen Y, et al.
MedComm (2020)
. 2024 Mar;
5(3):e501.
PMID: 38434760
This study aimed to evaluate the efficacy and safety of induction immunochemotherapy followed by definitive chemoradiotherapy (CRT) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC). We identified unresectable stage...
6.
Chen W, Wang C, Zhan W, Jia Y, Ruan F, Qiu L, et al.
Sci Rep
. 2024 Feb;
14(1):3569.
PMID: 38347102
No abstract available.
7.
Guo Y, Zhu Y, Zhang R, Yang S, Kepka L, Arruda Viani G, et al.
Transl Lung Cancer Res
. 2023 Jul;
12(6):1293-1302.
PMID: 37425405
Background: Stereotactic body radiotherapy (SBRT) has proven to provide high rates of tumor control for patients with early-stage non-small cell lung cancer (NSCLC). We are reporting a multicenter experience of...
8.
Yang S, Zhang J, Chen D, Ding J, Zhang Y, Song L
Drugs R D
. 2022 Sep;
22(4):271-279.
PMID: 36136273
Background And Objectives: Aspirin is a common drug for the treatment of pre-eclampsia. We aimed to explore whether quercetin as a supplement to aspirin could enhance the therapeutic outcome in...
9.
Huang X, Han Y, Yang S
Korean J Orthod
. 2022 Jul;
52(5):334-344.
PMID: 35844097
Objective: This study aimed to systematically analyze the effect and stability of miniscrew-assisted rapid palatal expansion (MARPE) to provide a reference for the clinical treatment of patients with maxillary transverse...
10.
Chen D, Yang S, Ding J, Liu A
Curr Mol Med
. 2022 May;
23(5):425-432.
PMID: 35570539
Background: Preeclampsia is a disorder of hypertension and proteinuria accompanied by abnormal inflammatory responses. Both aspirin and quercetin possess anti-inflammatory and anti-hypertensive properties. A low dose of aspirin is recommended...